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Manuscript 
Title 
Extent of resection and long-term survival of pineal region tumors in Helsinki Neurosurgery 
 
Abstract: 
Background: Pineal region tumors represent challenging surgical lesions with wide ranges of survival rates reported in 
different surgical series. Here, we emphasize the role of the complete microsurgical resection (CMR) in order to obtain 
a favorable long-term outcome of pineal region tumors. 
Methods: We report a retrospective study of pineal region tumors operated in Helsinki Neurosurgery between 1997 and 
2015. Information was obtained from the hospital records, and an evaluation of the Finnish population register was 
conducted in July 2018 to determine the current status of the patients.  
Results; 76 pineal region tumors were operated. The survival rate was 62 % at a mean follow up of 125±105 (0-588) 
months, and the disease-related mortality was limited to 14 (18.4%) patients. Up to July 2018, twenty-nine patients had 
died. 2 patients died 1 and 3 months after surgery with delayed thalamic infarctions, 12 patients with disease 
progression, and 15 had non disease-related deaths. Only one patient was lost in the long-term FU. 10/14 disease-related 
deaths occurred during the first 5 years of follow up: 5 diffuse gliomas, 3 germ cell tumors, 1 Grade II-III PPTID, and 1 
meningioma. CMR was linked to better tumor free survival and long-term survival rates with exception of diffuse 
gliomas.  
Conclusion: CMR, in the setting of a multidisciplinary management of pineal region tumors, correlates with favorable 
survival rates and with minimal mortality. Surgically treated grade II-IV gliomas conform a particular group with high 
mortality within the first 5 years independently of the microsurgical resection.  
 
Key words:  
Microneurosurgery, Multidisciplinary management, Pineal region lesions, Pineal tumors, Radiochemotherapy, Sitting 
position, Supracerebellar infratentorial approach 
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Introduction 
The pineal region or the so called posterior incisural space/quadrigeminal cistern is a deep intracranial structure that 
may harbor a big variety of neurosurgical diseases such as benign pineal cysts, a wide range of pineal region tumors, 
vascular malformations, and aneurysms.1–7 
The pineal region represents a microsurgical challenging location. Since the introduction of the operative microscope 
and, later, of the endoscope, the surgical outcome of these pathologies improved dramatically. On the other hand, in the 
last decades, the development of the radiochemotherapy has made possible, in selected cases, less invasive therapeutic 
modalities, in particular for germinomatous tumors.8–12 However, in opposition to all these therapeutic development, the 
diagnostic imaging of pineal region tumors still lacks precision, and histopathological and immunohistochemical 
examination is required for the definitive diagnosis. 
Even though the above-mentioned technical advances improved the surgical outcome of pineal region lesions and 
different surgical series reported wide ranges of survival rates, long term follow up data are still scarce in the 
literature.8–12  
Herein, we present the long-term surgical outcome of patients with pineal region tumors operated in Helsinki 
Neurosurgery (HN) between 1997 and 2015. Moreover, we aim to emphasize the importance of the complete 
microsurgical resection (CMR), in the setting of a multidisciplinary management of pineal region lesions 
(microneurosurgery and radiochemotherapy), in order to obtain a favorable long-term outcome. 
 
Methods 
 
Population 
Following the Institutional Ethics Board approval number HUS/2772/2017, we retrospectively reviewed the patients 
with pineal region tumors that were consecutively operated on in our department between 1997 and 2015. Few 
previously treated patients underwent surgical removal of a persistent or recurrent pineal lesion during the study period. 
Definitive histological diagnoses were recorded and, in case of unclear diagnosis, the histological samples were re-
revised by our neuropathologist. IMPAX version 6.5.5.1608 (Agfa, Mortsel, Belgium) was employed for the presurgical 
radiological evaluation, and for the post-operative imaging and evaluation of the extent of tumor resection as well. 
Finally, we examined the medical records to determine the preoperative status of the patients, the immediate and long 
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term clinical follow up of the patients, and one of the coauthors (RR) revised the Finnish population register in July 
2018 in order to determine their current status. 
The modified Rankin scale (mRS) was used to categorize and compare the preoperative, immediate postoperative, and 
long-term postoperative functional status of the patients. The correlations between the grade of microsurgical resection 
and mortality, pineal tumor free outcome, and volume of the lesion were analyzed using the Chi square and Mann-
Whitney U test. P values <0.05 were considered significant. SPSS version 22 (SPSS Inc., Chicago, IL, USA) was used. 
 
Complete microsurgical resection of pineal region lesions 
CMR was introduced as a key component of the protocol for the management of the pineal region lesions when the 
senior author (JH) became the chairman of the Department of Neurosurgery in Helsinki in 1997. Thus, the term 
“subtotal resection” (STR) of the tumor was conveniently coined to refer just a very small and usually firmly adhesive 
residual piece attached to the venous walls or infiltrating critical structures, after a procedure aiming at a complete 
removal of the lesion. Few biopsies were performed by other colleagues as a part of the initial management of the 
lesions.  
As above-mentioned, the pineal region is a very challenging surgical location because it is surrounded by critical 
neurovascular structures. Thus, the microsurgical principle “Simple, clean, fast and safe” under high operative 
magnification, is imperative for an efficient surgery.13–16 
  
General approach for pineal region lesions during the study period 
In HN, most of the patients harboring pineal region tumors associated with subacute or chronic symptoms are 
transferred from primary centers, the department of Neurology, or from some other hospitals across Finland or from 
abroad. Moreover, few cases are diagnosed as incidental findings after diagnostic imagining for unrelated symptoms. 
All patients harboring a pineal lesion underwent the following examinations: tumor markers in blood and cerebrospinal 
fluid (CSF), endocrine assessment, basal pituitary hormone tests, CSF sampling for cytology, CT studies, and MRI 
(T1WI, T2WI, T1 with gadolinium enhanced/Fat suppression, FLAIR, and diffusion weighted sequences). Moreover, 
proton density, spectroscopy, tractography, CSF flow studies, and MR angiography/venography, may also be 
additionally required. In general, the preoperative evaluation of the deep venous system is the most valuable factor in 
planning the surgical strategy of pineal region tumors. 
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The therapeutic decision after all preliminary studies is recommended by the neurooncological team composed by a 
neurosurgeon, an oncologist, a neuropathologist, a radiologist, and a neurologist. Once the histological diagnosis is 
confirmed, the neurooncological team determines all further management, and the required adjuvant treatment. 
In case of patients harboring pineal region tumors associated with hydrocephalus, acute and rapidly progressive 
hydrocephalus may initially require external ventriculostomy, endoscopic third ventriculostomy, 
ventriculoperitoneal/ventriculoatrial shunt, or direct removal of the lesions. This neurosurgical decision-making is 
related with the cytology study of the CSF, the presence of tumor markers in blood or CSF, and the preference of the 
surgeon. On the other hand, slow progressive hydrocephalus is generally treated by direct removal of the lesion. 
 
Pre-microsurgical stage 
Positioning and draping the patient are procedures made under the previously well-described protocol developed in 
Helsinki for a more ergonomic variant of the classic sitting position, the sitting praying position.1–5  
The supracerebellar infratentorial (SCIT) approach, which is suitable for infratentorial lesions behind and below the 
neurovascular structures, is the most frequently used route for pineal region surgery at our institution. Along the years a 
modified paramedian approach to the pineal region was perfected and performed routinely due to complications 
observed with the classic midline approach.3,16,17 The occipital interhemispheric (OIH) approach with our without 
transtentorial opening, is more suitable for tumors with large supratentorial segments extending behind and above the 
corpus callosum and the deep venous system. This approach is the second most frequently used at our institution and 
was widely described in another manuscripts.4,5 The transcortical, and the subtemporal approach are less frequently 
performed for lesions extended laterally to the temporo-occipital gyri. Other approaches might be also used according 
to specific locations of recurrent or residual tumors. 
 
Microneurosurgery  
When a proper pre-microsurgical stage is achieved, good microscopic job will be more fluent.16 Efficient 
microneurosurgery is only achieved after a continuous training, adequate knowledge of microsurgical principles and a 
proper neuroanatomical knowledge.  
We summarize our microsurgical strategy for approaching pineal region tumors as follow: 13,15 
1. After a suboccipital craniotomy, the dura is opened under the microscope based on the transverse sinus. An 
occipital interhemispheric approach requires a superior sagittal sinus-based dura opening. Strong retraction 
with dural stitches provides an adequate surgical view along the approaches. 
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2. Under high magnification, we access the quadrigeminal cistern after a SCIT approach and the pericallosal 
cistern whether the OIH approach is performed. In both cases, CSF is continuously released along the access 
instead of preoperative spinal catheter placement. On the other hand, opening of the cisterna magna is often 
unnecessary in SCIT approach.   
3. Along the SCIT approach, the quadrigeminal cistern is recognized as a dark tight membrane covering its dorsal 
and superior walls. We proceed to sharply open it uncovering the pineal tumor. After an OIH approach, the 
tumor may be directly recognized following the falx towards the splenium as no membrane covers the lesion.    
4. We proceed to coagulate and cut the posterior or superior walls of the tumor, and microsurgical ring forceps 
help us to obtain a tumor sample for the immediate and definitive histological study. 
5. A critical aspect before intending to remove the tumor consists in the proper preoperative evaluation of the 
MRI to define some degree of differentiation between the tumor and surrounding structures through some 
cleavage plane. Throughout our intraoperative evaluation, we could identify that opposite to infiltrative 
gliomas, most of pineal region tumors tend to preserve regular borders without aggressive microscopic 
infiltration of the surrounding parenchymal structures. This aspect remains as a key component for CMR 
without damage of the neurovascular structures. 
6. Internal decompression of the tumor with a thumb regulated suction and bipolar forceps or ring microforceps is 
followed by a conventional microsurgical dissection aiming to reach the posterior wall of the third ventricle. 
The tumor is separated from the adjacent neurovascular tissue, under soft but continuous traction using bipolar 
microforceps or ring microforceps. Cotton dissection and water dissection techniques are useful tools as well, 
and a microsurgical mirror or an endoscope may find out some residual tumor at the inferior hidden area. 
7. Another essential aspect along the microneurosurgery is closely related with the adherence and infiltration of 
the tumor into external layers of the deep venous system. The tumor should be carefully and softly dissected 
by water dissection technique, cotton dissection, and using microscissors and bipolar microforceps avoiding 
any vascular injury that may produce immediate or delayed complications. The postoperative evaluation of our 
“subtotal” resections demonstrated small residual pieces attached to these vessels. 
8. Microsurgical dissection of meningiomas follows same aforementioned principles. However, extreme caution 
should be taken while dissecting surrounding arterial and venous vessels. Moreover, falcotentorial attachments 
of the tumor should be sectioned aiming a CMR. 
9. Accurate hemostasis with a patient observation of any leak under continuous saline irrigation guaranties 
preventing postoperative hemorrhagic events.   
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
10. Closing under the microscope looks beneficial for a better hemostasis, precise wound margin approximation, 
atraumatic handling of tissues, and improvement of the surgical dexterity. All those elements, together with the 
use of a paramedian SCIT approach, instead of a more traumatic midline approach, associated to new dura 
sealing agents might be essential to reduce the high risk of postoperative cerebrospinal leak and meningitis in 
pineal region surgery.3,17 
 
Neuroanesthesia 
The main objective of neuroanesthesia is to maintain optimal perfusion and oxygen delivery to the central nervous 
system during the treatment. Moreover, intraoperatively, neuroanesthesia has to provide good surgical conditions. Some 
neuroanesthesiological considerations for pineal region surgery in sitting position were detailed previously.1,2  
 
Adjuvant therapy 
The radiation therapy and the chemotherapy represent essential tools in the management of pineal region tumors. They 
were used as adjuvant therapy few weeks after the microsurgical resection of pineal region tumors with aggressive 
behavior such as high grade gliomas, high grade pineal parenchymal tumors (PPT), germinomas, mixed germ cell 
tumors, immature teratomas, high grade ependymomas, papillary tumors of the pineal region (PTPR), microcellular 
metastases; and also after recurrences of those malignant and some more benign tumors such as meningiomas. In very 
few cases, radiochemotherapy was used as a primary line of treatment. Along our study and according to the current 
literature, we noticed new protocols emerging constantly. The different protocols used at our institution according to the 
definitive diagnosis of the tumor are described in Table 1. 
 
Results 
One hundred forty seven pineal regions lesions (pineal cysts, vein of Galen malformations, arteriovenous 
malformations, cavernous venous malformations, posterior cerebral artery aneurysms and pineal region tumors) were 
operated in HN between 1997 and 2015. Seventy-six patients with pineal region tumors (38 females and 38 males) were 
operated during the study period: 23 (30%) PPT, 12 (16%) germ cell tumors (GCT), 10 (13%) meningiomas, 10 (13%) 
pilocytic astrocytomas, 6 (8%) grade II-IV diffuse gliomas, and 15 (20%) other tumors (Table 3). The mean age of the 
patients was 38,4 ± 24 years (5 months - 82 years). The average length, height, and width of the lesions were 
respectively 2.8, 2.5 and 2.6 cm with maximal dimensions of 9x7.3x5.8 cm. Detailed information of the study 
population are summarized in Figure 1, Table 2 and 3. 
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Around 90% of the cases were initially operated by SCIT approach, and 10% by OIH approach. These two surgical 
approaches were combined in very few cases, at the same stage or in multiple stages. Other surgical routes (such as the 
suboccipital midline approach to the fourth ventricle, the anterior interhemispheric approach, the subtemporal approach, 
the occipital transtentorial approach, and the parietal transcortical approach) were selected in few cases or combined 
with the two above mentioned most used approaches. The senior author JH performed the microsurgical removal of 
most of the tumors. 
90% of the cases were operated on with patients in the sitting praying position. Other positions included the prone, 
supine, semisitting and park bench positions, particularly for biopsies, endoscopic procedures, brachytherapy, and for 
complementary multistage surgical procedures.  
The survival rate for our surgically treated 76 pineal region tumors was 62 % (47/76) at a mean follow up of 125±105 
(0-588) months. However, the disease-related mortality of our series was limited to 14 (18.4%) patients. Up to July 
2018, twenty-nine patients had died. No perioperative death was reported, 2 patients had delayed postoperative 
complications and died after 1 and 3 months since surgery, 12 patients had died with disease progression, and the other 
15 died with reasons unrelated to the disease. Eleven disease-related deaths occurred during the first 10 years of follow 
up: 5 diffuse gliomas, 3 GCT, 2 Grade II-III pineal parenchymal tumor of intermediate differentiation (PPTID), and 1 
meningioma. All of them except a grade II-III PPTID had died within the first 5 years. 
Only a foreign grade II-III PPTID patient was lost at the long term follow up after partial resection. Moreover, another 
foreign patient with a large hemangiopericytoma who was operated twice in Finland, was contacted by email in 2017. 
She was alive more than 11 years since the initial gross total resection of the lesion, with some dependency for her daily 
activities after the second surgery for a recurrent tumor in 2014.  
 
Pineal tumors in pediatric patients  
Pineal region tumors in 22 young patients (30%) with ages ranging between 0- and 21-year-old were mainly 
characterized by GCT, pilocytic astrocytomas, pineocytomas, pineoblastomas and diffuse gliomas. 
The first group of 10 patients (6 males, 4 females) includes children up to 6-year-old with 3 pilocytic astrocytomas and 
7 other tumors (ganglioneuroblastoma, GCT, archnoidal cyst, PTPR, WHO grade II glioma, pineoblastoma, 
pineocytoma). Six patients (60%) debuted with hydrocephalus, 7 (70%) patients underwent SCIT approach, and 7 
(70%) patients were operated on in the sitting position. Three disease related deaths (30%) belong to this group and 
only one patient is dependent at the last follow up (mRS:3). 
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The second group of 15 patients (10 males, 5 females) includes patients ranging between 14- and 21-year-old. The 
tumors were characterized by 7 GCT, 2 pineocytomas, 2 pilocytic astrocytomas, 1 pineoblastoma, 1 choroid plexus 
papilloma, 1 WHO grade II-III PPTID, 1 glioblastoma multiforme. Ten patients (67%) debuted with hydrocephalus, 14 
(93%) patients underwent SCIT approach, and the sitting position was employed in 14 (93%) patients. Four disease 
related deaths (27%) belong to this group and only one patient is dependent at the last follow up (mRS:4) 
 
Hydrocephalus and pineal tumors 
Fifty-three (70%) of the seventy-six studied patients presented with preoperative obstructive hydrocephalus 
(information about preoperative hydrocephalus was unavailable in two cases) (Table 2).  
Twenty-four of them underwent initial shunt surgery before tumor removal, two patients had initial endoscopic third 
ventriculostomy, while direct removal of the lesion was performed in twenty-seven patients. Most of the patients 
received initial shunt surgery during the first half of the study period. This group of patients underwent an average of 
more than two (2.3) shunt-related surgeries along the follow up. Seven patients undergoing initial shunt surgery 
suffered shunt removal due to different reasons and did not require a shunt device at the last radiological follow up. 
Three patients (two pediatric and one adult) with large pineal region pilocytic astrocytomas had the higher number of 
shunt-related surgeries with ten, six and five procedures, respectively. All of them underwent initial shunt surgery with 
multiple shunt disfunctions during the follow up. The patient with the ten shunt-related surgeries was a 2-year old boy 
with a giant tumor, initially considered inoperable who underwent shunt surgery and radiotherapy in 1985, 
brachytherapy in 1995, and microsurgical removal of the tumor only in 2000.   
Only one of the twenty-seven patients undergoing direct removal of the lesion required further endoscopic third 
ventriculostomy for persistent hydrocephalus due to a blood clot in the aqueduct. Finally, a ventriculoperitoneal shunt, 
still present at the last radiological follow up, was implanted in this patient. Regarding the two patients undergoing 
initial endoscopic ventriculostomy, one did not require any further treatment after complete resection of the lesion. 
However, the other patient underwent stereoscopic biopsy, shunt surgery due to persistent hydrocephalus, and 
brachytherapy. One more patient required endoscopic third ventriculostomy due to shunt disfunction after initial shunt 
surgery and removal of the tumor. At the last radiological evaluation, forty-nine patients (64%) of our study population 
did not require shunts. 
 
Microsurgical management of pineal region tumors 
Table 4 describes the differences between the CMR, STR, and partial resection of our pineal tumors series. 
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Complete microsurgical resection  
A CMR during the treatment was possible in 70% of the cases (53 patients). Only three of them (4%) showed 
recurrences in the pineal region at the last follow-up. A PPTID II-III and a meningioma are alive and have very small 
controlled recurrences 178 and 135 months after surgery. The third one, a patient with a locally recurrent germinoma 
and panventricular metastasis, died due to the progression of the disease 46 months after surgery and radiotherapy-
based adjuvant therapy. 
An anaplastic meningioma, and a diffuse grade II glioma had died 1 and 3 months after surgery with delayed 
postoperative infarctions. A patient with a pineoblastoma had multiple intracranial and spinal metastases without 
recurrence of the pineal tumor and died 173 months after surgery. A patient harboring a Glioblastoma multiform died 9 
months after the initial surgery; nevertheless, the lesion did not recur in the pineal region, but in the cerebellum with 
multiple foci and important edema. A mature pineal teratoma, which initially had concomitant small intraventricular 
and interhemispheric tumors, is still alive 229 months since the initial surgery, free of recurrence with very slowly 
growing concomitant lesions. Fifteen patients died in this CMR group with 5 disease-related deaths (2 gliomas, 1 
germinoma, 1 pineoblastoma, and an anaplastic meningioma). 
 
Subtotal resection 
A STR was achieved in 14 patients (18.4%) and, after adjuvant radiochemotherapy, only 2 of them were disease-free at 
the last follow up, an ependymoma and a mixed germ cell tumor that are alive 165 and 86 months after surgery. Five 
patients, 1 grade III glioma, 1 glioblastoma, 1 mixed GCT, 1 giant immature teratoma, and 1 giant grade II-III PPTID 
died respectively 52, 5, 11, 1, and 39 months after the initial surgery and a proper adjuvant therapy. The last 3 tumors 
had spinal metastases.  
Another PPTID II-III with very small controlled disease died from pneumonia few weeks after a suicide attempt. A 
patient with a gliosis/glioma died 2 months after surgery (the reason of death was unavailable). Four patients, 3 
pilocytic astrocytomas and 1 epidermoid tumor are alive with very small controlled lesions 231, 136, 139, and 376 
months after the initial surgery. Summarizing, seven patients died in this STR group with 5 disease-related deaths (2 
gliomas, 1 mixed germ cell tumor, 1 teratoma, and a PPTID II-III). 
 
Partial resection 
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A partial resection was carried out in 5 cases (6.6%): the resection of the cystic component of a germinoma initially 
treated by radiation therapy 6 years before, a grade III glioma with thalamic infiltration, a pineal meningioma associated 
with a lymphoma of the splenium, a giant pilocytic astrocytoma (that initially was unsuccessfully treated with external 
radiation therapy 15 years and later with brachytherapy 5 years before surgery), and a large PPTID II-III. The first four 
patients died 223, 12, 77, and 324 months after the initial surgery. The last PPTID was operated in a foreign patient, 
who was lost at the follow up. Thus, we had 3 disease-related deaths in this group. 
 
Biopsy and adjuvant therapy 
Two grade II-III PPTID followed biopsy and radiotherapy. One of them died with poor neurological condition and well 
controlled tumor, 8 years after brachytherapy. The other patient is alive 368 months after the initial procedure, without 
evident tumor at the imaging. 
 
We could not determine the grade of removal of the lesion in two patients harboring a ganglioneuroblastoma and an 
undefined tumor. Both died 23 and 35 months after surgery, respectively. Death reason was unavailable as well. 
 
Survival rate and surgical features of different type of tumors 
Throughout our analysis, we determined three well-differentiated groups of tumors. The first one has a very good 
survival outcome after surgical treatment and it is composed by arachnoid cysts, ependymomas, epidermoid tumors, 
hemangioblastomas, mature teratomas, papillary tumors of the pineal region, choroid plexus papilloma, pilocytic 
astrocytomas, pineocytomas, and solitary fibrous tumors/hemangiopericytomas. All of them represent 33% of the pineal 
region tumors and had an overall survival of 90-100% at an average follow up of 182±121 (45-588) months. Only 2 
patients died after a long follow up: an epidermoid tumor patient died 246 months after gross total resection without 
recurrence of the tumor, and a pilocytic astrocytoma 324 months after multiple combined therapies, respectively. 
Interestingly, we could recognize that the histologic phenotype of some tumor that underwent two or more surgeries, 
such as a WHO grade I Pilocytic astrocytoma, a WHO grade II papillary tumor of a pineal region, and a WHO grade II 
Hemangiopericytoma, evolved into more aggressive WHO grade II, III, and III tumors, respectively, between surgeries.  
Grade II-III PPTID, pineoblastomas, germinomas and non germinomatous GCT with exception of mature and immature 
teratomas represent 38% of tumors in the pineal region and had a moderate survival between 60 to 70% at an average 
follow up of 132±86 (0-368) months. Germinomas, the most radiosensitive tumors, were diagnosed in 7 patients. CMR 
was achieved in 71% of the cases. We had 2 deaths in our series. A patient underwent CMR of a local germinoma and 
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adjuvant pineal-panventricular radiotherapy without chemotherapy. One year after the initial treatment the patient had a 
metastatic spinal recurrence controlled by radiochemotherapy. However, 2 years after the initial treatment the patient 
presented small recurrences in the left frontal horn and in the third ventricle with no response to adjuvant therapy and 
with posterior multiple large panventricular metastases. The patient died 46 months since surgery. Another patient was 
treated initially with radiation therapy after a biopsy in 1992. In August 1998, the patient returned to the department 
with a residual tumor and a large cystic component in the pineal region. The patient underwent partial resection with 
removal of the cystic component. In 2010, the patient had a stroke event and the MR imaging revealed a spinal 
metastatic tumor that required radiochemotherapy. The patient with multiple intracranial and spinal metastases died in 
2011, 223 months after the initial treatment.  
Ten meningiomas of the pineal region represent 13% of the tumors with 50% of overall survival at an average follow up 
of 94.5±56 (1-205) months. Even though this group has a high mortality, only a case suffered a delayed postoperative 
thalamic infarction and died 1 month since surgery. Two patients had died due to multisystemic atrophy and an 
intractable lymphoma of the corpus callosum respectively, while the other 2 patients died at 91 and 83 years old without 
recurrence of the lesion and without postoperative complications. All of them underwent CMR except a patient with a 
lymphoma of the corpus callosum that underwent partial resection. Two falcotentorial meningiomas included in this 
series had superior and anterior location with a minimal tentorial component. 
Gliomas, immature teratomas, ganglioneuroblastomas, microcytic cancer metastases, and neuroepithelial cysts are 
lesions with very bad prognosis in our series. They represent 13% of the tumors, and all of them died between 1 and 68 
(mean: 18±23) months. The neuroepithelial cyst and the microcytic metastasis died of reasons unrelated to the 
intracranial lesion. The median survival rate for the rest of these tumors was 5 months.  
 
Clinical follow up and mortality  
Preoperatively, 15 (19.7%) patients harbored independent functional status with a mRS 0-2, and 59 (77.6%) patients 
had some degree of dependency with a mRS 3-5. Information was unavailable in 2 patients. Regarding the immediate 
postoperative follow up, 55 (72.4%) patients achieved a mRS 0-2, and 18 (23.7%) patients had a mRS ≥ 3. Information 
was unavailable in three patients; however, no perioperative mortality was reported. At the last clinical evaluation, 14 
(18.4%) disease-related deaths (mRS 6) were reported. 48 (63.2%) patients had a mRS 0-2, and 12 (15.8%) patients had 
a mRS 3-5. Information was unavailable in 2 patients (Table 2). Moreover, evaluation of the Finnish population register 
in July 2018 revealed other 15 death patients without disease-related complications. Eight patients died of reasons 
unrelated to the disease, and the information regarding the death in patients with good operative outcome was 
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unavailable in 6 patients. A patient harboring an undefined apoplexic tumor who died 3 months after surgery did not 
register a specific reason of death. However, we highly suspect a death related to the course of the disease.  
 
Complete microsurgical resection and mortality of the disease 
As mentioned, 14 disease-related deaths were found in our series. Two of these patients, an anaplastic meningioma, and 
a diffuse grade II glioma had delayed postoperative thalamic infarctions and died 1 and 3 months after surgery, 
respectively. A patient with a giant immature teratoma had a good postoperative recovery, however, the postoperative 
MRI a week after surgery revealed spinal metastasis. The patient died at home 1 month after surgery. A WHO grade II-
III PPTID patient, neurologically disabled, died 39 months after surgery. Eight patients with diffuse grade II-IV gliomas 
(4), germ cell tumors (3), and a pineoblastoma died of disease progression. A PPTID patient with very small controlled 
tumor after biopsy and brachytherapy died 8 years after the procedure with a slowly progressive neurological 
impairment. A giant pilocytic astrocytoma patient, who initially underwent biopsy and radiotherapy followed by 
brachytherapy few years later and finally multiple surgeries after the senior author became the chairman in Helsinki 
Neurosurgery, died more than 27 years after the initial treatment. 
Table 5 summarizes the characteristics of those 14 disease-related deaths. 2 patients died of delayed postoperative 
complications, 7 patients had a progressive tumor growth with intracranial and/or spinal metastases, and 5 patients died 
without or with very small controlled pineal region tumor, but with intracranial or spinal metastases in 4 of them. The 
most aggressive tumors were diffuse grade II-IV gliomas followed by non germinomatous GCT. Overall, at 5-years 
follow-up, the mortality of both, gliomas plus non germinomatous GCT, represents the 50% of the entire mortality 
related to the disease. Moreover, the mortality of diffuse gliomas did not correlate with the degree of surgical resection; 
differently from the two non germinomatous GCT, which were subtotally resected and died due to progressive disease. 
An anecdotal glioblastoma case underwent CMR without local recurrence along the follow up. However, multiple 
cerebellar foci with important peritumoral edema appeared at the last stage of the disease and were the cause of death. 
Another illustrative case is represented by a patient with a germinoma who died 46 months after surgery, despite a 
CMR and a successive pineal-panventricular radiotherapy. 
 
Discussion 
We report our results of 76 pineal region tumors operated between 1997 and 2015 in the centralized Department of 
Neurosurgery-Helsinki University Hospital, which covers around 1,6 million people from the south area of Finland.18 
62% of the patients were alive at the last follow up; however, the disease-related mortality was limited to 14 (18.4%) 
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patients. Up to July 2018, twenty-nine patients had died with only one patient lost in the long term-FU. Eleven disease-
related deaths occurred during the first 10 years of follow up: 5 diffuse gliomas, 3 germ cell tumors, 2 Grade II-III 
PPTID, and 1 meningioma. All of them except a grade II-III PPTID had died within the first 5 years. According to our 
analysis, the complete microsurgical resection was linked to better tumor free survival and long-term survival rates with 
exception of diffuse grade II-IV gliomas.  
CMR of pineal region tumors seems effective for the treatment of concomitant hydrocephalus. Initial shunt surgery 
before removal of the tumor is associated to an increased number of shunt-related surgeries, particularly in those 
patients who underwent subsequent incomplete removal of the lesion. The number of initial endoscopic third 
ventriculostomies in our series is small and prevent to generate conclusions. However, two of our four patients required 
further shunt-surgery for persistent hydrocephalus. We believe that small ostomies associated with a reduced experience 
of the surgeon might play a role in this regard.  
The protocol for the management of all pineal tumors along the study period remained similar. A complete 
microsurgical resection was our primary aim in most of the cases, with very few cases undergoing initial biopsy and 
subsequent adjuvant radiochemotherapy. However, currently, the policy for the management of pineal region lesions 
with hydrocephalus in our department, as in other specialized centers, includes endoscopic third ventriculostomy 
associated with tumor biopsy and further management, particularly in case of high suspicion of radiosensitive 
germinomas. In this regard, risks of intraprocedural bleeding, inadequate sampling, and inappropriate definitive 
management should be taken into account. 
The approach to pineal region tumors in children did not have substantial changes compared to the adult population. 
The supracerebellar infratentorial approach was the most frequently used. The sitting praying position was also 
performed as frequent as in adult patients. However, tight elastic bandages in the lower extremities replaced the 
unavailable antigravity trousers for small children.2,19 Particular anesthetic considerations for pediatric population, as 
earlier described, consist in the use of ringer solution, saline solution with antibiotics, and manitol at average volumes 
of 600 ml., 200 ml., and 125 ml., respectively; and the occasional use of hydroxyethyl starch in bigger volumes than in 
adult patients.19  
 
Sitting praying position  
The head of the patient, which is tilted beyond the projection of the anterior wall of the thorax, is usually 20°-30° 
flexed, preserving a distance between the chin and sternum. For this purpose, the table is bent around 90°-100° 
elevating the upper torso of the patient. All this sequence maintains the horizontal axis of the tentorium parallel to the 
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floor, with less than 90° in relation to the axis of the surgeon. The Anesthesia Team will modify the position of the table 
according to the requirements of the surgeon. In pineal region surgery, other surgical positions such as the prone, 
semisitting or park bench positions are rarely utilized when an absolute contraindication for the sitting position exists, 
or when the lesion is better accessed by a different approach. Inside the operation room, teamwork coordination is 
essential. This proper teamwork can be clearly exemplified with the immediate reaction of the anesthesiologist in case 
of venous air embolism during the surgery. The access and compression of both jugular veins by the anesthesiologist is 
very effective to find the leak, which is repaired by the surgeon using hemostatic agents or direct suturing.1–3 
 
The supracerebellar infratentorial approach 
The supracerebellar infratentorial paramedian approach (SCIT), a less invasive variant of the midline suboccipital 
approach, represents an efficient surgical approach to the pineal region we developed in the last years due to the relative 
high rate of complications with the classic midline approach, as shown in Table 6.3,6,17 Using this approach the pineal 
region is accessed over the superior surface of the cerebellar hemisphere. The quadrigeminal cistern is opened laterally 
without damaging the midline vascular structures. Moreover, thanks to the gravity effect offered by the praying sitting 
position, a retraction less approach might be performed.   
 
Outcome and long term follow up 
The long term follow up in our series allowed us to determine properly the course of the managed pineal region lesions. 
Thus, recurrences after complete resection, or incomplete removal followed by standard adjuvant therapy and functional 
outcome were clearly seen.  
Large data analysis about unselected pineal region tumors might be summarized as follow. Pineal tumors in the French 
National Register, which included pineal parenchymal tumors (PPT), germ cell tumors, gliomas, pineal cysts, and 
primitive neuroepithelial tumors had an average survival of 49% within an average follow up of 5.8 (1-23) years. From 
452 patients, 328 underwent direct surgery, and 164 (50%) had a complete removal (50%), 24% a partial removal, and 
in the 26% of the patients the quality of removal were not mentioned. The overall mortality was 137 patients (30%), and 
20% of the patients were lost at the follow up. The overall postoperative mortality was 1.8%. They mentioned that after 
ten years patients were considered cured and the follow-up ended.8  
Pineal tumors in the surveillance, epidemiology, and end results data of cancer in the United States mainly based on 
GCT, PPT, and gliomas published in 2010, had a 5-year overall survival of 65% ± 2.1%, and the median survival time 
was 19.3 years. The 5-year overall survival for GCT was 78.9%, 61% for gliomas, and 47.2% for PPT. According to 
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their analysis, non–germ cell tumors and no radiotherapy were factors associated with a negative outcome. The extent 
of surgical tumor resection did not affect survival in any histologic subgroup. However, the disclosed information 
revealed that surgical data was available for 552 patients: 224 patients had no surgery, only 32 (6%) underwent total 
excision, and 296 had other surgeries.9  
Data of Brain Tumor Registry of Japan revealed that the most frequent tumor in the pineal region was germinoma 
(49.2%) followed by pineocytoma (8.5%), glioma (6.5%), pineoblastoma (5.1%), malignant teratoma (5.2%), and other 
teratomas (5.1%). The 5-year survival rate of germinomas, pineocytomas, and pineoblastomas was 89.4%, 84.1% and 
46.1%, respectively.10 Burdenko Neurosurgery Institute in Russia reported their results of 287 patients with 
histologically verified pineal region tumors from 700 pineal tumors mainly distributed as GCT (31%), PPT (27%), glial 
tumors (27%), and miscellaneous (15%). Gross total resection was achieved in 148 operations (58%), subtotal resection 
in 74 (29%) and partial in 33 (13%). The projected 5-year and 10-year survival rates were: 95% and 88% for 
germinomas, 80% and 50% for high grade gliomas, 44% and 0% for high grade PPT, and 20% and 0% for malignant 
GCT, respectively.11  
A report from the international gamma knife research foundation after stereotactic radiosurgery for pineal region tumors 
described an actuarial local control and survival rates of 81% and 76% at 20 years for pineocytomas, 50% and 56% at 5 
years for PPTID, 27% and 48% at 5 years for pineoblastomas, 33% and 100% at 5 years for papillary tumors of the 
pineal region, 80% and 80% at 20 years for germinomas, and 61% and 67% at 5 years for tumors of unknown 
histology.12  
Our survival rates were superior to those published in the literature. Moreover, the evaluation of the Finnish population 
register to determine the current status of our patients remarks the validity of our study. The analysis of the overall 
survival of our series uncovered some tumors of bad prognosis such as metastatic tumors, immature teratomas, 
ganglioneuroblastomas, and gliomas II-IV. However, the specific mortality analysis determined that grade II-IV 
gliomas are the unique type of lesion characterized by very aggressive behavior, independently of the degree of 
resection, and are associated with high mortality during the first five years after surgery. The second most aggressive 
lesion corresponds to some non germinomatous GCT, particularly immature teratomas and mixed GCT, whose 
mortality correlates with the degree of resection. Other tumors with a progressive disease in spite of CMR were a 
germinoma that underwent radiotherapy-based adjuvant therapy, and a pineoblastoma with a metastatic recurrence 14 
years after surgery.  
PPTs except pineocytomas are usually reported as tumors with bad prognosis. 100% of our pineocytoma patients and 
pineoblastoma patients were alive more than 20 and 10 years, respectively. On the other hand, the 5-and 10-year 
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survival rate for our grade II-III PPTIDs were 92% and 71%, respectively. On the basis of the current literature as well 
as of our data, we strongly believe that the good surgical outcome of PPT patients is directly related with the CMR 
followed by a proper adjuvant radiochemotherapy.20–22 
Primary glioblastomas in the pineal region are well documented by the literature and show an average survival of 7 
months.23 Similarly, a comprehensive literature review of gliomas in the pineal region revealed that grade II and III 
gliomas have a dismal outcome compared to their hemispheric counterparts. On the other hand, grade I pilocytic 
astrocytomas have a good prognosis. In this regards, the categorization of pilocytic astrocytomas and non pilocytic 
grade II-IV pineal gliomas would better represent the prognosis of this entity.24  
Our results confirm these findings. Pilocytic astrocytomas had a very good prognosis with a 5-year and 10-year overall 
survival rate of 100%. However, giant tumors requiring multiple surgeries were usually described. CMR was possible 
in 60% of the cases. Only partial resection was possible after external and internal radiotherapy in a particular giant 
tumor. On the other hand, and in spite of our small number of diffuse grade II-IV gliomas, we may conclude that these 
tumors have a high mortality during the first 5 years after surgery, which does not correlate with the extent of the 
surgical resection. 
Meningiomas of the pineal region might be divided as falcotentorial and velum interpositum meningiomas. Frequent 
recurrences are observed in patients after subtotal resection, and with atypical and anaplastic meningiomas. However, 
some authors justify the partial resection of the meningiomas, and the use of radiosurgery for residual tumors or local 
recurrences attached to the deep venous system, since severe neurological complications have been reported in the 
literature after occlusion of the deep venous system.25–28 Even though, in our series, the mortality related to surgical 
complications is reduced to a patient, we consider extremely important the recognition and the preservation of the deep 
arterial and venous systems, which are commonly involved into the tumor, particularly in large meningiomas. Whether 
those structures are insufficiently dissected, radiation therapy might play an important role in the management of 
residuals or recurrent tumors.  
The current literature supports the radiochemotherapy as the first line of treatment for germinomas. This is based on the 
excellent outcomes in the North Asian population series, where germinomas account for more than 40% of the pineal 
region tumors.10,29 However, in our population, where germinomas represent less than 10% of our pineal tumors, the 
protocol for their management becomes challenging. Since the senior author introduced the CMR as a primary concept 
for the management of pineal lesions, the immediate intraoperative histological analysis did not offer a consistent 
diagnosis of the lesions. Moreover, as almost 50% of our germ cell tumors were non germinomatous and mixed tumors, 
with less response to radiation and chemotherapy, radical removal of the lesions had to be performed. Currently, based 
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on the development of magnetic resonance imaging and serum or cerebrospinal fluid tumor markers, we may 
accomplish a better screening of these lesions that might allow us to perform biopsies followed by radiochemotherapy.  
Herein, we present our long term results about tumors of the pineal region. Even though important findings were 
reached, future research is required to determine the impact of the adjuvant radiochemotherapy associated to the CMR 
in every specific group of pineal lesions. Diffuse gliomas of the pineal region remain challenging lesions for 
neurosurgeons and require important research for alternative management. Our internal analysis gave us already a clue 
about the correlation between different protocols of radiation therapy and chemotherapy and the survival of tumors, 
such as PPT or germinomas. On the other hand, future research is also needed to extend the surveillance analysis of the 
present series in order to report longer follow up outcomes. After all, we may also remark that it is extremely important 
to determine the treatment modality for these rare and complex lesions, based on the oncological advisory commission 
of every neurooncological department.8 
A limitation of this study remains in the retrospective approach of the cases. However, as pineal tumors are rare, we still 
aim to enhance the importance of the microneurosurgery as a treatment modality for a favorable long-term outcome. 
 
Conclusion 
Complete microsurgical resection, in the setting of a multidisciplinary management of surgically treated pineal region 
tumors in HN, correlates with favorable tumor free survival and long-term survival rates with minimal postoperative 
mortality. Surgically treated diffuse gliomas of the pineal region should be considered a particular group harboring high 
mortality independently of the microsurgical resection.  
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Figure Legends 
 
Fig.1 Age distribution in patients with pineal region tumors in the Department of Neurosurgery, Helsinki University 
Hospital. 
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Table 1. Different adjuvant therapy protocols used at Helsinki Neurosurgery according to the definitive diagnosis 
of the tumor 
Tumor Radiotherapy Chemotherapy 
Glioblastoma multiforme  
 
• 54 Gy of focal fractionated external 
radiotherapy  
• Multiple doses of Temozolomide 
150mg/m2  
Pineoblastoma  • Fractionated external radiotherapy with 
36 Gy craniospinal radiation and 
additional 18 Gy boost of radiation on the 
tumoral bed after gross total resection.  
• Medulloblastoma protocol: 
initially, vincristine 1.5mg/m2 
once a week for 6 weeks is set. Six 
weeks after this initial treatment, a 
new scheme of chemotherapy is 
administrated every 6 weeks with 
8 cycles of lomustine: 
75mg/m2x1; cisplatino: 
75mg/m2x1; and vincristine: 1,5 
mg/m2x3 on days 0, 7, and 14.  
• It is employed for children and 
patients with high risk of 
metastases such as incomplete 
resection or tumor recurrences. 
Grade II-III Pineal parenchymal 
tumor of intermediate 
differentiation. 
• Fractionated external radiation therapy 
with 54 Gy divided in a daily dose of 1.8-
2Gy was delivered in selective cases, 
such as high grade PPTID with 
pleomorphic histology including 
pineoblastoma features, after partial 
resection of the lesion and, after 
recurrence of the tumor at the follow up. 
• Brachytherapy with iodine-125 seeds was 
used in a case 
• No chemotherapy was 
administered in our series, but we 
recommend to use it in case of a 
pediatric presentation  
A large recurrent grade III 
papillary tumor of the pineal 
region in a pediatric case  
• Fractionated external radiotherapy of 
54Gy divided in a daily dose of 1,8Gy 
after gross total resection. 
• High grade ependymoma protocol: 
cisplatin-cyclophosphamide-
vincristine-etoposide, delivered in 
four intravenous cycles, each 
lasting 21 days: 1) days 1, 8, and 
15 for the first three cycles: 
vincristine, 1.5 mg/m², 2) days 1, 
2, 3: etoposide, 100 mg/m², 3) day 
1: cisplatin, 100 mg/m², and 4) 
days 2, 3: cyclophosphamide, 1000 
mg/m². 
Ependymoma. • Fractioned radiation therapy with 54 Gy 
was used for a small remnant in a grade I-
II 
• Recommended in high grade 
ependymomas as mentioned 
above. 
Germinoma • Currently, fractionated radiotherapy of 
45Gy (30,6 ventricular area and a booster 
of 14,4Gy to the hypophysis-pineal 
region) divided in a daily dose of 1,8Gy. 
• Post radiation chemotherapy with 
etoposide 100mg/m2 days1-5, 
cisplatin 20mg/m2 days 1-5, and 
bleomycin 30,000 IU days 1, 8, 
and 15. 
Mixed germ cell tumors • Fractionated radiotherapy. Variable doses 
of craniospinal radiotherapy or whole-
• Chemotherapy after gross total 
resection based on the above 
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Table 2. Characteristics of the 76 patients with surgically treated pineal region tumors.  
 
Population  76 patients; Age: 38,4 ± 24 (0.4 - 82) years; 38 females and 38 males 
Symptoms of presentation 
Symptoms: anosmia, ataxia, balance disturbances, cognitive deficits, disorientation, facial and 
corporal sensory deficits headache, memory deficits, nausea, psychomotor disturbances, 
seizures, tremor, vomit, unconsciousness, urinary incontinence, vertigo, walking difficulties, 
motor deficits. 
Visual and oculomotor abnormalities: anisocoria, double vision, Parinaud´s syndrome, visual 
field defects, and unspecific visual disturbances. 
Rare presentations: apoplectic hemorrhage, Asymptomatic germ cell tumor with diabetes 
insipidus and hormonal imbalance. 
Hydrocephalus in pineal tumors: 
53 patients (70%) 
Initial treatment: 
Initial shunt surgery before tumor removal: 24 patients. Mean: 2.3 (1-10) shunt related 
surgeries.  
Endoscopic third ventriculostomy: 2 patients 
Direct removal of the tumor: 27 patients   
Pineal tumor Size (cm) Mean (Maximal): Length: 2.8 (9) cm; Height: 2.5 (7.3) cm; Width: 2.6 (5.8) cm 
Surgical approach 
Supracerebellar infratentorial approach: ± 90% 
Occipital interhemispheric approach: ± 10% 
Other approaches: combined supra and infratentorial approaches, anterior interhemispheric 
approach, telovelar approach, subtemporal approach, transcortical approach 
Surgical position Sitting position:  90%; Others (supine, park bench):  10% 
Microsurgical resection Complete: 53; Subtotal: 14; Partial: 5; Biopsy: 2; UI: 2  
Preoperative functional status mRS 0:4; mRS 1:3; mRS 2:8; mRS 3:17; mRS 4:28; mRS 5:14; UI: 2 
Immediate postoperative 
evaluation mRS 0:3; mRS 1:22; mRS 2:30; mRS 3:8; mRS 4:7; mRS 5:3; UI: 3  
Functional status at the last 
clinical evaluation, 125±105 
(0.5-588) months; and deaths in 
mRS 0: 20; mRS 1: 15; mRS 2: 13; mRS 3: 7; mRS 4: 3; mRS 5: 2; mRS 6: 14; UI: 2  
Deaths in July 2018: 29 (14 disease related, 8 unrelated to the disease, 6 unknown reason of 
death)  
ventricular radiation therapy are applied 
according to the poor or intermediate 
prognosis of the lesion based on the 
histopathology (poor: yolk sac tumor-
choriocarcinoma-embryonal carcinoma; 
intermediate: germinoma-teratoma) and 
serum markers (poor >2000 UI) of α-
fetoprotein and β-human chorionic 
gonadotropin. 
etoposide-cisplatin-bleomycin 
protocol 
Immature teratoma  • Requires radiochemotherapy. However, 
the unique case in our series had a bad 
neurological outcome and did not receive 
any complementary treatment. 
 
Microcellular metastases  •  30 Gy of whole brain external radiation 
therapy. 
• Chemotherapy according to the 
primary tumor 
Small recurrent meningiomas or 
pilocytic astrocytomas  
• Mainly treated by focal external radiation 
therapy. 
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July 2018  
Final status at the last clinical 
evaluation 
Improved: 54 (20 symptom free) patients 
No change in mRS: 4 patients (2 patients were dependent due to other comorbidities) 
Worsened: 17 patients (14 disease related deaths) 
UI: 2 
mRS: modified Rankin Scale; UI: unavailable information 
 
Table 3. Pineal region tumors operated in HUH between 1997-2015 
Diagnosis Cases Survival 
rate (%) 
5-year 
survival 
rate (%) 
10-year 
survival 
rate (%) 
Follow up (months)  
Pineal parenchymal tumors:  
 16 PPTID # 
 3 pineoblastomas  
 4 pineocytomas 
23 70 
63 
67 
100 
95 
92 
100 
100 
88 
71 
100 
100 
160±89 (0-368) 
143±100 (0-368) 
161.3±13 (147-173) 
224.5±18 (204-246) 
Germ cell tumors 
 7 germinomas 
 1 mature teratoma 
 1 immature teratoma 
 3 mixed germ cell tumors  
12 67 
71 
100 
0 
67 
72 
86 
 
 
 
57 
75 
 
 
 
106±81 (1-229) 
113,7±75 (46-223) 
229 
1 
11, 86, and 148 
Pilocytic astrocytomas * 10 90 100 100 143.7±88 (52-324) 
Meningiomas 10 50 89 75 94.5±56 (1-205) 
Diffuse gliomas (WHO grade II, III and IV) 
 1 WHO grade II gliomas  
 2 WHO grade III gliomas 
 2 Glioblastoma multiforme 
 1 Quadrigeminal glioma/gliosis 
6 0 
 
- 
 
- 
 
13.8±19 (2-52)  
3 
12-52 
5-9 
2 
Solitary fibrous tumor-Hemangiopericytoma 2 100   45, and >132 
Ependymoma 2 100   122-165 
Epidermoid  2 50   246-376 
Arachnoid cyst& 1 100   172 
Ganglioneuroblastoma 1 0   23 
Hemangioblastoma 1 100   78 
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Microcytic cancer metastasis 1 0   8 
Neuroepithelial cyst 1 0   68 
Papillary tumor of the pineal region  1 100   54 
Choroid plexus papilloma 1 100   588 
Undefined tumors 2 0   3-35 
Total 76 62 84 76 125±105 (0-588) 
PPTID, pineal parenchymal tumor of intermediate differentiation 
#
 A PPTID case did not have a histology report 
*
 Three cases were reported as atypical, diffuse type and a tumor change from a grade I astrocytoma to grade II 
after one year from partial resection. One case belongs to an anterior vermis region tumor. 
&
 Wide microsurgical fenestration of the cyst with complete obliteration observed at the follow up. 
 
 
Table 4. Differences between the complete microsurgical resection, subtotal resection, and partial resection of 76 
pineal tumors operated in Helsinki Neurosurgery between 1997 and 2015 (P value calculated between CMR and 
STR+PR as No-CMR). 
Grade of surgical 
resection* 
Complete microsurgical resection 
70% (53) 
Subtotal resection 
18% (14) 
Partial resection 
7% (5) 
P value 
General Mortality 28% (15/53)  50% (7/14)  80% (4/5)  P<0.05 
Mortality of the 
disease  
9% (5/53)  36% (5/14)  60% (3/5)  P<0.01 
Pineal tumor free at 
last FU 
94% (50/53)  14% (2/14)  0% (0/5)  P<0.001 
Pineal tumor 
volume (mm3)  
9773±11952 (500-53261) 25660±33764 (392-122500) 31387+-34255 (5750-90000) P=0.2 
Mortality of the 
disease 
2 diffuse gliomas, 1 germinoma, 1 
pineoblastoma, 1 anaplastic 
meningioma. 
2 diffuse gliomas, 1 mixed 
germ cell tumor, 1 teratoma, 
and a PPTID II-III 
Germinoma, a diffuse glioma, 
and a giant pilocytic 
astrocytoma 
 
FU, follow up; CMR, Complete microsurgical resection; PPTID, pineal parenchymal tumor of intermediate 
differentiation; PR, partial resection; STR, subtotal resection 
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*4 cases, 2 cases that underwent biopsies, and 2 cases with unavailable information were excluded from the 
analysis. The absolute number of cases is written between parentheses. 
 
Table 5. Mortality related with complications of the surgery or progression of the disease. 
Tumor (total 
number of 
cases) 
Mortality 
along the 
FU (cases) 
  
Mortality 
in the first 
5 years 
(cases) 
CMR  Reason of death 
(surveillance in 
months) 
STR Reason of 
death 
(surveillanc
e in months) 
P
R 
Reason of 
death 
(surveillance 
in months) 
B+B
T 
Reason of death 
(surveillance in 
months) 
Grade II-IV 
glioma (6) 
83 % (5) 83 % (5) 
 
2 Thalamic Infarction 
(3 m.), 
CT+cerebellar 
infiltration (9 m.) 
2 PT+ICI (5 
and 52 m.) 
1 PT+ICI (12 
m.) 
    
Grade II-III 
PPTID (16) 
13 % (2) 6 % (1)     1 CT+SI (39)     1 CT+brain 
atrophy, 
rigidity, aphasia 
(101 m.) 
Germinoma 
(7) 
29 % (2) 14 % (1) 1 PT+ICI (46 m.)     1 PT+ICI+SI 
(223 m.) 
    
NGGCT (5) 40 % (2) 40 % (2)     2 CT+SI (1 
m.), PT+ICI 
(11 m.)  
        
Meningioma 
(10) 
10 % (1) 10 % (1) 1 Thalamic Infarction 
(1 m.) 
            
pilocytic 
astrocytoma 
(10) 
10 % (1) 0 % (0)         1 PT+ICI (324 
m.) 
    
Pineoblastoma 
(3) 
33 % (1) 0 % (0) 1 CT+ICI(pons)+SI 
(173 m.) 
            
Total 14 10 5  5  3  1  
 B+BT, biopsy plus brachytherapy; CT, controlled tumor; CMR, complete microsurgical resection; ICI, 
intracranial infiltration; NGGCT, non germinomatous germ cell tumor; PR, partial resection; PT, progressive 
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tumor; PPTID, pineal parenchymal tumor of intermediate differentiation; SI, spinal infilration; STR, subtotal 
resection. 
 
Table 6. Supracerebellar infratentorial approach and postoperative complications in surgery of pineal region 
tumors (Chi-Square, p<0.05). 
 
Approach Postoperative complications related to 
the approach 
% 
Midline supracerebellar infratentorial 
approach 
(number of patients: 28) 
Bacterial meningitis: 4  
Wound infection: 3 
Epidural hematoma: 1 
(8 patients) 
29% 
Supracerebellar infratentorial 
paramedian approach 
(number of patients: 35) 
Wound infection: 2 
Cerebrospinal fluid leak: 1 
(3 patients) 
9% 
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Abbreviations and Acronyms  
CMR, complete microsurgical resection; CSF, cerebrospinal fluid; HN, Helsinki Neurosurgery; GCT, 
germ cell tumors; mRS, modified Rankin scale; OIH, occipital interhemispheric approach; PPT, pineal 
parenchymal tumors; PPTID, pineal parenchymal tumor of intermediate differentiation; SCIT, 
supracerebellar infratentorial paramedian approach; STR, subtotal resection 
 
